I WANT SO MUCH TO LIVE explores the pioneering efforts of Genentech and the many individuals who came together to develop Herceptin, the world's first 'targeted therapy' for breast cancer.
No media sources available
I WANT SO MUCH TO LIVE explores the pioneering efforts of Genentech and the many individuals who came together to develop Herceptin, the world's first 'targeted therapy' for breast cancer.